UK markets open in 2 hours 23 minutes
  • NIKKEI 225

    26,417.56
    -387.04 (-1.44%)
     
  • HANG SENG

    22,002.58
    +5.69 (+0.03%)
     
  • CRUDE OIL

    110.06
    +0.28 (+0.26%)
     
  • GOLD FUTURES

    1,817.30
    -0.20 (-0.01%)
     
  • DOW

    31,029.31
    +82.32 (+0.27%)
     
  • BTC-GBP

    16,541.34
    -292.17 (-1.74%)
     
  • CMC Crypto 200

    431.19
    -8.47 (-1.93%)
     
  • ^IXIC

    11,177.89
    -3.65 (-0.03%)
     
  • ^FTAS

    4,019.53
    -15.71 (-0.39%)
     

Provision of the draft information memorandum

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
Generix Group
Generix Group

As announced on June 13, New Gen Holding SAS filed on June 15, 2022 a simplified public offer for Generix Group shares at a price of €9.50 per share, plus an additional €0.50 per share if the threshold of 90% of the share capital and voting rights is reached at the end of the offer.

The project of a simplified takeover bid and the Draft Prospectus remain subject to the review of the AMF.

The Draft Prospectus is available on the websites of the AMF (www.amf-france.org) and Generix Group (www.generixgroup.com/fr) and may also be available free of charge from the registered office of Generix Group (ArteParc Lille-Lesquin (Bâtiment 2A), 2 rue des Peupliers - 59810 Lesquin) and from Alantra (7 rue Jacques Bingen - 75017 Paris)

In accordance with article 231-28 of the general regulation of the AMF, the information relating to the characteristics, particularly the legal, financial, and accounting characteristics of New Gen Holding SAS and Generix Group will be filed with the AMF and made available to the public no later than the day before the opening of the simplified public tender offer. A press release will be issued to inform the public of the procedures for making this information available.

Following the acquisition of Generix Group shares as described in the previous press release published by Generix Group on June 13, 2022, New Gen Holding currently holds 55.52% of the capital and 53.13% of the theoretical voting rights of Generix Group.

New Gen Holding, Montefiore and Generix Group's managers acting in concert hold 67.18% of Generix Group's capital and 65.24% of its theoretical voting rights.

In the event of the exercise of the 4,433,552 stock warrants that will be acquired by New Gen Holding under the agreements concluded with the managers, and without taking into account the securities that would be contributed to the simplified takeover bid, the aforementioned concert would hold 72.54% of Generix Group's capital and the Floating Share would hold 27.36% of the Company's capital.

INVESTOR CONTACT

Financial Communication Contact: François Théry - Chief Financial Officer - +33 (0)1 77 45 42 80 - fthery@generixgroup.com

Investor Relations: Julia Bridger – EuroLand Corporate - +33 (0)1 44 70 20 84 - jbridger@elcorp.com

This press release has been prepared for informational purposes only and does not constitute an offer to purchase securities. The distribution of this press release, the offer and acceptance thereof may be restricted by law in certain jurisdictions. Persons into whose possession this press release comes should inform themselves of and observe any applicable legal restrictions. New Gen Holding disclaims any liability for any violation by any person of any applicable legal restrictions.

Attachment


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting